• GLP-1 (9-36) Amide: Mechanistic Insights for GLP-1R Antagoni

  2026-06-11

  GLP-1 (9-36) amide is a rigorously validated glucagon-like peptide-1 receptor antagonist, essential for dissecting GPCR signaling in metabolic and type 2 diabetes research. This article details its mechanism, evidence, and critical workflow parameters, providing clarity on its specificity and application boundaries.

• IPA-3 (1-[(2-hydroxynaphthalen-1-yl)disulfanyl]naphthalen-2-

  2026-06-11

  IPA-3 is a selective, non-ATP-competitive inhibitor of Pak1, targeting its autoregulatory domain to block autophosphorylation and kinase activity. It exhibits high selectivity in vitro and in vivo, with well-characterized solubility and storage properties. IPA-3 is a robust tool for dissecting Pak1-driven pathways in cancer, cell motility, and neuroinflammation research.

• Rotenone: Precision Modeling of Mitochondrial Dysfunction in

  2026-06-10

  Explore how Rotenone, a gold-standard mitochondrial Complex I inhibitor, enables advanced modeling of Parkinson’s disease and neurodegenerative pathways. This in-depth perspective blends mechanistic insight, translational strategy, and workflow guidance—highlighting critical findings, protocol best practices, and the evolving research landscape.

• BKT140 (BL-8040): Next-Generation CXCR4 Inhibition in Precis

  2026-06-10

  Explore the advanced role of BKT140 (BL-8040), a potent CXCR4 antagonist, in cutting-edge tumor microenvironment modeling and hematopoietic stem cell mobilization assays. This article uniquely bridges mechanistic insight with practical assay guidance for oncology research.

• Network-Based Identification of Apigenin for Alzheimer’s The

  2026-06-09

  A recent network medicine study systematically identified apigenin as a promising flavonoid candidate for Alzheimer’s disease intervention, demonstrating its neuroprotective and anti-inflammatory mechanisms. These findings expand the translational landscape for apigenin, suggesting practical avenues for both mechanistic and workflow-driven AD research.

• Brassinolide: Mechanistic Insights & Strategic Value for Tra

  2026-06-09

  This thought-leadership article explores Brassinolide as a dual-function agent in plant development and biomedical models, focusing on underlying mechanisms, evidenced translational applications, and practical guidance for researchers. By connecting recent advances in structure–activity relationships with best-practice experimental design, we help investigators harness Brassinolide’s unique potential across oncology and metabolic disease studies.

• Bradykinin B2 Receptors Inhibit Ileal Peristalsis via Reflex

  2026-06-08

  This study provides the first direct evidence that bradykinin B2 receptors mediate inhibition of the peristaltic reflex in guinea pig ileum. By dissecting receptor-specific actions using selective agonists and antagonists, the research clarifies bradykinin's role in gastrointestinal motility—an insight with significant implications for hypertension and ACE inhibitor research.

• HucMSCs Restore Vasculogenesis via MAPK Pathway Under High G

  2026-06-08

  This study elucidates how human umbilical cord mesenchymal stem cells (hucMSCs) counteract the impairment of vasculogenesis caused by high glucose, primarily by modulating the MAPK signaling pathway. The findings highlight the distinct vulnerability of early vascular development to hyperglycemia and propose hucMSCs as a therapeutic avenue for diabetic vascular complications.

• Cell Cycle Assay Kit: Precision Analysis of G0/G1, S, G2/M P

  2026-06-07

  Leverage the Cell Cycle Assay Kit (Catalog No. K2263) for high-resolution, reproducible assessment of cell cycle progression and apoptosis. This protocol-focused guide details advanced use-cases, troubleshooting, and practical enhancements for accurate flow cytometry analysis in cancer and cell biology research.

• Dynamic Remodeling of CNS Myelin Sheaths After Damage

  2026-06-06

  Arafa et al. reveal that myelin sheaths in the central nervous system (CNS) can withstand damage through a dynamic remodeling process, rather than undergoing inevitable degeneration. Their findings suggest new intervention points for demyelinating disorders, highlighting the importance of early myelin pathology and the interplay between neuronal activity and myelin integrity.

• Bismuth Subsalicylate in GI Disorder Research: Protocols & I

  2026-06-05

  Bismuth Subsalicylate (1,3,2λ2-benzodioxabismin-4-one) is redefining gastrointestinal disorder research by enabling precise inflammation pathway modulation and robust modeling of membrane biology. Discover advanced workflows, troubleshooting strategies, and practical enhancements for translational studies leveraging this high-purity, water-insoluble compound supplied by APExBIO.

• Shionone Activates Mitophagy via PINK1-Parkin to Combat Pulm

  2026-06-05

  This study reveals that shionone, a natural terpenoid, alleviates pulmonary fibrosis by stimulating mitophagy through the PINK1-Parkin pathway. The findings highlight a novel anti-fibrotic mechanism, suggesting mitophagy modulation as a promising therapeutic target and supporting the relevance of sensitive oxidative stress assays for mechanistic research.

• Lovastatin as an HMG-CoA Reductase Inhibitor: Applied Workfl

  2026-06-04

  Lovastatin enables precise dissection of cholesterol metabolism and cell signaling pathways by inhibiting HMG-CoA reductase with nanomolar potency. This guide details experimental workflows, troubleshooting, and research-driven innovations for maximizing its impact in cancer, apoptosis, and cellular biology applications.

• Hemagglutinin mRNA Vaccine Protects Dairy Cows From H5N1 Inf

  2026-06-04

  This study demonstrates that a hemagglutinin-based mRNA–lipid nanoparticle vaccine provides robust and durable protection against H5N1 influenza virus in lactating dairy cows, a population vulnerable to recent outbreaks. The findings showcase the feasibility and potential of mRNA vaccine technology in large livestock, opening new avenues for disease control in agriculture and public health.

• Necrostatin-1: Unraveling RIP1 Kinase Inhibition in Inflamma

  2026-06-03

  Explore how Necrostatin-1, a potent RIP1 kinase inhibitor, uniquely advances mechanistic studies of necroptosis, inflammation, and tissue injury. This article delivers a deeper, application-driven analysis with insights from ferroptosis research and new protocol guidance.

451 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page